ArticleInterdisciplinary sciences, computational life sciences2026
MBPBERT: A Large Language Model for Metal-Binding Peptide Discovery.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Metal-binding peptides (MBPs) are a class of peptides capable of selectively coordinating metal ions and play critical roles in various biological processes, such as metal ion transport, storage, catalysis, and signal transduction. However, traditional experimental approaches, such as mass spectrometry, chromatography, and nuclear magnetic resonance spectroscopy, are labor-intensive, time-consuming, and poorly suited for the large-scale screening of MBPs. To overcome these limitations, we introduce MBPBERT, a deep learning-based predictive framework for accurate identification of MBPs and discrimination of metal-specific binding subtypes. MBPBERT builds upon the ProteinBERT architecture and was developed using two curated datasets: a peptide pretraining corpus comprising 33,095 sequences and a labeled dataset containing 909 MBPs and non-MBPs. For rigorous external validation, an independent test dataset of 101 peptides was constructed. MBPBERT attained areas under the receiver operating characteristic curve (AUROCs) of 0.9414 and 0.8882 on the test dataset for the prediction of MBPs and the classification of their specific binding subtypes, respectively. These results underscore the framework's strong predictive capability and generalization performance. Thus, MBPBERT provides a scalable and efficient in silico solution for high-throughput discovery of novel MBPs and screening of peptides with metal-specific binding preferences, potentially reducing the reliance on resource-intensive experimental validation.
Indexed as
Identifiers
42663806What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.